Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Molecular Oncology|December 15, 2015
Development of a circulating miRNA assay to monitor tumor burden: From mouse to manAlastair Greystoke, Mahmood Ayub, Dominic G Rothwell, et al.The Analyst|November 26, 2015
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancerJakub Chudziak, Deborah J Burt, Sumitra Mohan, et al.Journal of Physical Activity & Health|May 5, 2010
Master plans for pedestrian and bicycle transportation: community characteristicsLesley Steinman, Mark Doescher, David Levinger, et al.BMC Genomics|December 19, 2014
Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cellsDominic G Rothwell, Yaoyong Li, Mahmood Ayub, et al.British Journal of Cancer|April 29, 2023
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancerRebecca Kristeleit, Ruth Plummer, Robert Jones, et al.Molecular Oncology|July 26, 2017
Molecular analysis of single circulating tumour cells following long-term storage of clinical samplesBarbara Mesquita, Dominic G Rothwell, Deborah J Burt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced CancerRobert Jones, Ruth Plummer, Victor Moreno, et al.Tumori|April 27, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trialsLuca Agnelli, Andrea Villa, Fouziah Butt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid TumorsBabar Bashir, Judy S Wang, Gerald Falchook, et al.Nature Medicine|November 22, 2016
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancerLouise Carter, Dominic G Rothwell, Barbara Mesquita, et al.Pageof 5